Article
Mechanisms involved in the evolution of progestin resistance in human breast cancer cells.
Cancer research - 15 Apr 1991
Murphy L C, Dotzlaw H, Wong M S, Miller T, Murphy L J
Abstract excerpt
The emergence of resistant cells reduces the efficacy of many forms of drug therapy in human breast cancer. In order to understand some of the possible mechanisms by which hormonally dependent human breast cancers develop resistance to progestin therapy we have developed a human breast cancer cell line (5-RP) which is resistant to the growth inhibitory effects of progestins in culture. These cells routinely grow...
Topics
- Antineoplastic Agents
- Breast Neoplasms
- Cell Division
- Drug Resistance
- Gene Expression Regulation, Neoplastic
- Growth Substances
- Humans
- Medroxyprogesterone
- Medroxyprogesterone Acetate
- Neoplasms, Hormone-Dependent
